Module 9 2024

03/09/2024

Special Cases

Orphan drugs

Biosimilars

Shortages/Need

Approval will be based on Risk/Benefit assessment

The Organisation for Professionals in Regulatory Affairs

43

Thank You

Any Questions?

The Organisation for Professionals in Regulatory Affairs

44

22